SYM-210: Communicating and Evaluating Adverse Events Associated with an FDA-Approved Medical Device | ASCRS
Presentation
SYM-210: Communicating and Evaluating Adverse Events Associated with an FDA-Approved Medical Device
May 2019
Meeting: 2019 Annual Meeting
Session: SYM-403: X-Rounds: Refractive Cataract Surgery to the Max
Presenters: Natalie Afshari, MD; Malvina B. Eydelman, MD; Stephen Lane, MD; Jonathan Talamo, MD; Francis S. Mah, MD; Douglas J. Rhee, MD; Leon W. Herndon, Jr., MD
You must be logged in to view this content

This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.

The 2019 ASCRS FDA symposium will spotlight the FDA efforts to assure the safety and effectiveness of medical technologies used in the United States. Specifically, this symposium will address the FDA’s process for evaluating adverse events associated with an FDA-approved medical device and those that have been withdrawn from the market.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.